This mechanistic study revealed that CCL17 recruits Th2 cells through binding to CCR4, thus perturbing T cell subset balance, promoting fibrotic-factor release (predominantly IL-4 and IL-17), and resulting in cardiac hypertrophy, fibrosis, and subsequent HF. The gene discussed is IL17A; the disease is cardiac hypertrophy.